JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Koray Ak
Selim Isbir
Atike Tekeli
Selami Dogan
Ali Civelek
Sinan Arsan
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ak, K.
Right arrow Articles by Arsan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ak, K.
Right arrow Articles by Arsan, S.
Related Collections
Right arrow Extracorporeal circulation

J Thorac Cardiovasc Surg 2007;134:477-483
© 2007 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass

Koray Ak, MDa,*, Selim Isbir, MDa, Atike Tekeli, MDa, Arzu Ergen, PhDb, Nazan Atalan, MDc, Selami Dogan, MDd, Ali Civelek, MDa, Sinan Arsan, MDa

a Marmara University School of Medicine, Department of Cardiovascular Surgery, Istanbul, Turkey
b Istanbul University School of Medicine, Institute of Experimental Medical Research, Department of Molecular Medicine, Istanbul, Turkey
c Özel Academic Hospital, Department of Anesthesiology and Reanimation, Istanbul, Turkey
d Johann Wolfgang Goethe University, Department of Cardiovascular Surgery, Frankfurt Main, Germany.

Received for publication February 10, 2007; revisions received March 1, 2007; accepted for publication March 12, 2007.

* Address for reprints: Koray AK, MD, Marmara University Hospital, 34640 Altunizade Istanbul, Turkey. (Email: akkoray{at}hotmail.com).

Objective: Current data suggest that individual genetic predisposition may influence the magnitude of cytokine response and the degree of organ dysfunction after cardiopulmonary bypass. Lipoprotein lipase S447X polymorphism has been shown to be protective against atherosclerosis. The aim of the study was to investigate the effect of lipoprotein lipase S447X polymorphism on cytokine release and early outcome after cardiopulmonary bypass.

Methods: Forty patients who underwent coronary artery bypass grafting with cardiopulmonary bypass were included. Genotyping for lipoprotein lipase S447X polymorphism was performed by polymerase chain reaction. Levels of interleukins 6 and 8 were measured before induction and 6, 24, and 72 hours after operation by enzyme-linked immunosorbent assay. Clinical data were collected prospectively. Daily assessment of organ dysfunction was done according to the cardiac surgery scoring (CASUS) system.

Results: The allele frequency of lipoprotein lipase S447X stop codon was 17.5%. S447X carriers revealed significantly lower interleukin 8 levels at the sixth and 24th postoperative hours than the noncarrier group (P = .005 and P = .041, respectively). Patients in the S447X carrier group had significantly shorter ventilation times than the noncarrier group (P = .048). Also, the S447X carrier group revealed significantly lower postoperative 6-hour lactate levels, operative day, and postoperative day 1 organ dysfunction scores than the other group (P = .001, .005 and .002, respectively).

Conclusion: Lipoprotein lipase S447X stop codon mutation is associated with lower levels of interleukin 8 after coronary artery bypass grafting. Identification of high-risk patients for cardiopulmonary bypass–related systemic inflammation by detecting lipoprotein lipase S447X stop codon polymorphism may improve early postoperative outcome, especially in patients with limited organ reserves.



Abbreviation and Acronyms APACHE = Acute Physiology and Chronic Health Evaluation; CABG = coronary artery bypass grafting; CASUS = cardiac surgery scoring; CK = creatine kinase; CPB = cardiopulmonary bypass; ICU = intensive care unit; IL = interleukin; MODS = Multiple Organ Dysfunction Score; LPL = lipoprotein lipase; SIRS = systemic inflammatory response syndrome; TNF = tumor necrosis factor





This article has been cited by other articles:


Home page
In VivoHome page
H. Y. AYDOGAN, S. ISBIR, O. KURNAZ, U. GORMUS, and T. ISBIR
Associations of Lipoprotein Lipase S447X and Apolipoprotein E Genotypes with Low-density Lipoprotein Subfractions in Turkish Patients with Coronary Artery Disease
In Vivo, January 1, 2009; 23(1): 155 - 161.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.